Poseida Therapeutics to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day

SAN DIEGO, May 23, 2023 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced that the Company’s President of Gene Therapy, Brent Warner,…

About the Author

has written 41558 stories on this site.

Copyright © 2010 Business and Corporate News.